A business theme involving contracts with overseas medical device manufacturers that lack a sales base in Japan, and the introduction of their products into Japanese clinical practice by leveraging regulatory approvals and a nationwide distribution network. It includes expanding the domestic exclusive distribution of products made by overseas manufacturers, such as devices for structural heart disease treatment.